Dishman Carbogen Amcis Intrinsic Value
Dishman Carbogen Amcis intrinsic value. Dishman Carbogen Amcis (DCAL) median intrinsic value is ₹296.32 from 4 valuation models (range ₹237–₹296), vs current price ₹118.53 — +150.0% upside (Trading Below Calculated Value), margin of safety 60.0%. For current market price and key ratios, visit Dishman Carbogen Amcis stock price NSE.
DCAL Valuation Methods Summary — DCF, Graham Number & P/E
Dishman Carbogen Amcis intrinsic value across 4 models vs current price ₹118.53 — upside/downside and value range per method. Browse DCAL income statement for revenue, profit, balance sheet and cash flow data.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹296.32 | ₹266.69 - ₹325.95 | +150.0% | Book Value/Share: ₹2153.87, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹237.06 | ₹213.35 - ₹260.77 | +100.0% | Revenue/Share: ₹659.35, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹237.06 | ₹213.35 - ₹260.77 | +100.0% | EBITDA: ₹200.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹296.32 | ₹237.06 - ₹355.58 | +150.0% | CF Growth: 8.5%, Discount: 15% |
DCAL Intrinsic Value vs Market Price — All Valuation Models
Dishman Carbogen Amcis fair value range ₹237–₹296 vs current market price ₹118.53 across 4 valuation models. Analyse DCAL shareholding pattern to track promoter, FII and institutional holdings.
DCAL Intrinsic Value Analysis — Undervalued or Overvalued?
Dishman Carbogen Amcis median intrinsic value ₹296.32, current price ₹118.53 — Trading Below Calculated Value by 150.0%, margin of safety 60.0%.
What is the intrinsic value of DCAL?
Based on our comprehensive analysis using 4 different valuation methods, the estimated intrinsic value of Dishman Carbogen Amcis (DCAL) is ₹296.32 (median value). With the current market price of ₹118.53, this represents a +150.0% variance from our estimated fair value.
The valuation range spans from ₹237.06 to ₹296.32, indicating ₹237.06 - ₹296.32.
Is DCAL undervalued or overvalued?
Based on our multi-method analysis, Dishman Carbogen Amcis (DCAL) appears to be trading below calculated value by approximately 150.0%.
DCAL Financial Health — Key Ratios vs Industry Benchmarks
Dishman Carbogen Amcis financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Return on Equity | -4.0% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 9.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.17x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
DCAL Cash Flow Quality — Operating & Free Cash Flow
Dishman Carbogen Amcis operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹492 Cr | ₹370 Cr | Positive Free Cash Flow | 8/10 |
| March 2025 | ₹371 Cr | ₹275 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹379 Cr | ₹267 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹266 Cr | ₹19 Cr | Positive Free Cash Flow | 7/10 |
| March 2022 | ₹355 Cr | ₹46 Cr | Positive Free Cash Flow | 7/10 |